Moisturizers, Lubricants, and Vulvar Hygiene Products: Issues, Answers, and Clinical Implications
- 286 Downloads
Genitourinary syndrome of menopause (GSM) is a group of symptoms that encompasses vulvovaginal atrophy (VVA), and affects more than half of all postmenopausal females. There are many etiologies that may cause GSM-like symptoms including declining hormone levels, post partum lactation, medications, and certain medical illnesses. GSM is often under-recognized by both the woman and her health care professional. VVA can cause a constellation of signs and symptoms including irritation, pain burning, and itchiness. Although systemic and local hormonal treatment is often recommended, many women may decline their use or opt for a more conservative approach. Numerous women are opting for over-the-counter products for their dryness solutions, including moisturizers, lubricants, and vulvar washes to help manage these symptoms. There is a lot of consumer confusion concerning these products, and with a plethora of varieties on the market, it is easy for the woman to get confused concerning type of products and the additives and chemical that maybe found within them. This review article summarizes the common characteristics of vaginal moisturizers, lubricants, washes, and dispels some of the misperceptions concerning common chemical/additives found in these products. It is important for the reader to note that trade names of several over-the-counter products are mentioned throughout the manuscript and this should not be interpreted as a specific product endorsement.
KeywordsVulvar hygiene products Genitourinary syndrome of menopause Vulvovaginal atrophy Moisturizers Lubricants Review
Compliance with Ethical Standard
Conflict of Interest
Jamie Patterson and Leah Millheiser declare that they have no conflict of interest. Michael L. Krychman reports grants from NERI and Evidera; has served as advisor and speaker for Shionogi and Sermonix; and has received fees as consultant for Uniderm, Rickett Benckiser, and Pfizer.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 2.Portman DJ, Gass ML. Vulvovaginal atrophy terminology consensus conference panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s sexual health and the North American Menopause Society. Climateric. 2014;17:557–63.CrossRefGoogle Scholar
- 4.Wysocki S, Kingsberg S, Krychman M. Management of vaginal atrophy: implications from the REVIVE survey; clinical medicine insights. Reprod Health. 2014;8:23–30.Google Scholar
- 5.Krychman ML. Vaginal estrogens for the treatment of dyspareunia. J Sex Med. 2011 Mar;8(3):666–74.Google Scholar
- 7.Birnholtz JC. Sexual lubricants promoting health and pleasure. Medical Aspects of Human: Sexuality; 1998.Google Scholar
- 9.Carter J, Goldrank D, Schover L. Simple strategies for vaginal health promotion in cancer survivors. Journal of Sexual Medicine. 2011;8:549–59.Google Scholar
- 17.Fevola MJ, Gentner L, Ahmad N, Librizzi JJ. Getting intimate with polymers: personal lubricants. Cosmetics and Toiletries. 2008;123:59–68.Google Scholar
- 19.• Chen J, Geng L, Song X, H. L, Giordan N, O. L. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J Sex Med. 2013;Volume 10(Issue 6):1575–84. This article is important as it illustrates that there are some important components that should be included in intimate vaginal products. Women must read labels to be aware what is included and what other potential caustic ingedients should be avoided.Google Scholar
- 20.Bailey AJ. Collagen and elastin fibres. J Clin Path. 31(Suppl. (Roy. Coll. Path.), 12):49–58.Google Scholar
- 21.Karpuzoglu E, Holladay SD, Gogal Jr RM. Parabens: potential impact of low-affinity estrogen receptor binding chemicals on human health. J Toxicol Environ Health B Crit Rev. 2013;16:321–35.Google Scholar
- 24.Accessed on August 4th 2016. Website:ACS: http://www.cancer.org/cancer/cancercauses/othercarcinogens/athome/antiperspirants-and-breast-cancer-risk
- 27.Fashemi B, Delaney ML, Onderdonk AB, Fichorova RN. Effects of feminine hygiene products on the vaginal mucosal biome. Microb Ecol Health Dis. 2013;24. doi: 10.3402/mehd.v24i0.19703 .eCollection 2013
- 32.World Health Organization. Use and procurement of additional lubricants for male and female condoms: WHO/UNFPA/FHI360 advisory note 2012 [7 July 2015]. http://apps.who.int/iris/bitstream/10665/76580/1/WHO_RHR_12.33_eng.pdf
- 42.Mowat A, Newton C, Boothroyd C, Demmers K, Fleming S. The effects of vaginal lubricants on sperm function: an in vitro analysis. J Assist Reprod Genet. 2014;31:333–9 http://www.menopause.org/for-women/sexual-health-menopause-online/effective-treatments-for-sexual-problems/vaginal-and-vulvar-comfort-lubricants-moisturizers-and-low-dose-vaginal-estrogen.CrossRefPubMedPubMedCentralGoogle Scholar